88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Kelun-Biotech Announces 2026 Interim Results CHENGDU, China , Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (" Kelun-Biotech " or the " Company ", Stock Code: 6990.HK ) announces its ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
New Study Confirms Capsugel® Enprotect® Capsules Deliver Robust Gastric Integrity Under Both Fasted and Fed Conditions SEOUL, South Korea , Aug. 14, 2026 /PRNewswire/ -- Enteric capsules are widely used to protect acid-sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting ... 2026-08-17T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics NANJING, China and SINGAPORE , Aug. 14, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ("MediSix"), a Singapore-based ... 2026-08-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate Phase 1b study will evaluate safety and pharmacokinetics of RSM01 in approximately 80 infants aged 2 weeks to 8 months Company expands its global portfolio beyond vaccines into antibody-based preventive ... 2026-08-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial SHANGHAI , Aug. 14, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) ... 2026-08-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innorna Nominated for 2026 Prix Galien USA Best Startup Award HONG KONG SAR, China and SHENZHEN, China and CAMBRIDGE, Mass. , Aug. 13, 2026 /PRNewswire/ -- Innorna, a clinical-stage biotech company advancing RNA medicines, today announced that it has been nominated ... 2026-08-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mervyn's Petcare Marks One Year at Magnify Incubator on UCLA campus with Launch of Second Feline Supplement on Amazon SEOUL, South Korea , Aug. 13, 2026 /PRNewswire/ -- Ari's Purrfect Omega+Multivitamin Lickable Supplement expands the Feline First product line as Yuyu Pharma's U.S. pet subsidiary approaches a full ... 2026-08-13T Biotechnology
Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026 NEW DELHI , Aug. 13, 2026 /PRNewswire/ -- Axtria Inc. , a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward Deployed ... 2026-08-13T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
/DISREGARD RELEASE: IASO Bio/ We are advised by IASO Bio that journalists and other readers should disregard the news release, IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics, issued ... 2026-08-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved